ABCDEFGHIJKLMNOPQRSTUVWXY
1
Last updated:May 2022
Malaria Consortium's seasonal malaria chemoprevention research projects
2
3
StudyStatusDescriptionResults available?Source 1Source 2Source 3Source 4
4
Fifth SMC cycleCompleteA typical SMC round involves four cycles of SMC administration during the four months of the rainy season. This study, conducted in one district in Burkina Faso, pilots the addition of a fifth monthly cycle to the SMC round to assess its feasibility and impact on malaria incidence.Results are available (see cell note).Malaria Consortium, Research and impact report, 2019Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020Traore 2020
5
Age eligibilityCompleteSMC is typically targeted at children aged 3–59 months, though coverage data suggests that it is often administered to children outside of this age range. This study, conducted in Chad, examines common barriers to accurately determining age eligibility and the feasibility of extending SMC administration to children aged 5-10 years.Results are available (see cell note).Malaria Consortium, Research and impact report, 2019Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020Malaria Consortium, Chad age eligibility research brief, 2021Moukénet et al. 2022
6
Vitamin A integrationCompleteThis study, conducted in one LGA in Nigeria, pilots the integration of SMC administration and vitamin A distribution into one campaign.Results are available (see cell note).Malaria Consortium, Research and impact report, 2019Malaria Consortium, Co-implementing vitamin A supplementation with seasonal malaria chemoprevention: A pilot implementation study in Sokoto state, NigeriaMalaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020
7
Data accuracy CompleteThis study sought to assess how useful Health Management Information System (HMIS) data are for measuring the impact of SMC and other malaria control programs. It compared HMIS with data from outpatient registers at 14 health facilities in Massaguet district, Chad. Results are available (see cell note).Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020
8
IPC guideline adherenceCompleteMalaria Consortium, in partnership with national malaria programs and co-implementers, carried out a mixed-methods, multi-country study in Burkina Faso, Chad, and Nigeria to assess adherence by community distributors to IPC (infection prevention and control) guidelines. Results are available (see cell note).Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020Malaria Consortium, SMC COVID-19 IPC study report, 2021Ward et al. 2022
9
Geospatial platform usabilityCompleteMalaria Consortium, in collaboration with Akros, pilot tested Reveal, a geospatial platform, in one LGA in Sokoto state, Nigeria. Data analysis is complete. Malaria Consortium is not planning to submit for publication.Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020Adesoro 2020
10
Implementing SMC in MozambiqueIn progressMalaria Consortium is conducting a two-year implementation research study of SMC in Nampula, Mozambique. Research activities are ongoing. Phase 1 is complete and phase 2 is in progress.Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020Wharton-Smith et al. 2021Malaria Consortium, SMC Mozambique project brief, 2021Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2021
11
Implementing SMC in UgandaIn progressMalaria Consortium is conducting a two-year implementation research study of SMC in Karamoja, Uganda.Research activities are ongoing. Data analysis for phase 1 is ongoing and phase 2 has received ethical approval.Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020Malaria Consortium, SMC Karamoja, Uganda synposis, 2021Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2021
12
Role model approachIn progressThe role model approach is a community-driven behavior change strategy that identifies existing strengths or solutions among individuals in a community, which are then shared with other community members to bring about positive changes in behavior. Malaria Consortium is exploring this approach to address the challenges associated with SPAQ administration in Burkina Faso, Chad and Togo, and to find existing, local solutions for improvement. Data analysis is ongoing and full results will be published in 2022.Malaria Consortium, Using the role model approach to improve administration of seasonal malaria chemoprevention drugs in Burkina Faso, Chad and Togo, 2021Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2021
13
Lead mothersIn progressLead Mothers (LMs) are female members of the community who conduct health promotion activities in Nigeria. Although LMs have been working on SMC campaigns for a number of years, the impact of their role on the SMC program has not been evaluated. In 2021/22, Malaria Consortium, with the National Malaria Elimination Programme in Nigeria, is conducting a study to assess and then optimize the role of Lead Mothers in SMC campaigns in Kano state, northern Nigeria. Data collection and analysis are ongoing and results will be published in 2022.Malaria Consortium, Optimising the role of lead mothers during the seasonal malaria chemoprevention campaign in Kano state, Nigeria: A mixed-methods study, 2021Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2021
14
Vitamin A integrationIn progressFollowing the 2019 study (see row 6), in 2021, Malaria Consortium conducted further research to test the co-implementation of SMC and vitamin A supplementation at a larger scale and in both rural and urban settings in two local government areas (LGAs) of Bauchi state. Preliminary findings are available (see cell note). Full results will be published in 2022.Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2021Malaria Consortium, VAS integration project brief, 2021
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100